(5-342) Does the cost incurred by the institution for inpatient use of Dificid (fidaxomicin) outweigh the benefit of Dificid (fidaxomicin) over oral vancomycin
Monday, December 9, 2024
4:15 PM – 5:15 PM
Location: Hall G, Lower Level
Category: Research-in-Progress Topic: Drug Information/Drug Use Evaluation